{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:14:24Z","timestamp":1785212064625,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"FDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.04.088","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:21:13Z","timestamp":1559222473000},"page":"3730-3734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007\u20132017"],"prefix":"10.1016","volume":"37","author":[{"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Arana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Barash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0795-9164","authenticated-orcid":false,"given":"Beth F.","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.088_b0005","unstructured":"Kroger AT, Duchin J, V\u00e1zquez M. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). [www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/downloads\/general-recs.pdf]. Accessed on April 12, 2019."},{"key":"10.1016\/j.vaccine.2019.04.088_b0010","first-page":"245","article-title":"Clinical safety evaluation of combination vaccines","volume":"95","author":"Midthun","year":"1998","journal-title":"Dev Biol Stand"},{"issue":"9","key":"10.1016\/j.vaccine.2019.04.088_b0015","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00006454-200209000-00014","article-title":"Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheriatetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination","volume":"21","author":"Pichichero","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-8","key":"10.1016\/j.vaccine.2019.04.088_b0020","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"CDC","year":"1997","journal-title":"MMWR Recomm Rep"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2019.04.088_b0025","first-page":"1","article-title":"Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"CDC","year":"1997","journal-title":"MMWR Recomm Rep"},{"issue":"18","key":"10.1016\/j.vaccine.2019.04.088_b0030","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1982.03320430055032","article-title":"Simultaneous administration of influenza and pneumococcal vaccines","volume":"247","author":"DeStefano","year":"1982","journal-title":"JAMA"},{"issue":"RR-17","key":"10.1016\/j.vaccine.2019.04.088_b0035","first-page":"1","volume":"55","author":"Kretsinger","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR-3","key":"10.1016\/j.vaccine.2019.04.088_b0040","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"36","key":"10.1016\/j.vaccine.2019.04.088_b0045","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.04.088_b0050","unstructured":"Medical Dictionary for Regulatory Activities. Available at: http:\/\/www.meddramsso.com\/. Accessed April 28, 2011."},{"key":"10.1016\/j.vaccine.2019.04.088_b0055","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals. http:\/\/www.ich.org\/products\/meddra.html. Accesed on June 10, 2018."},{"key":"10.1016\/j.vaccine.2019.04.088_b0060","first-page":"52252","article-title":"21 CFR Part 600.80. Postmarketing reporting of adverse experiences","volume":"62","author":"Food and Drug Administration","year":"1997","journal-title":"Fed Regist"},{"issue":"20","key":"10.1016\/j.vaccine.2019.04.088_b0065","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2016.03.049","article-title":"Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011\u20132015","volume":"34","author":"Moro","year":"2016","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2019.04.088_b0070","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2015.05.006","article-title":"Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000\u20132013","volume":"33","author":"Hibbs","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.088_b0075","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.105.1.e11","article-title":"Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children","volume":"105","author":"Pichichero","year":"2000","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.088_b0080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","article-title":"A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children","volume":"100","author":"Pichichero","year":"1997","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.088_b0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.inf.0000202082.56403.c4","article-title":"How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?","volume":"25","author":"Halperin","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.04.088_b0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2334-9-165","article-title":"Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study","volume":"9","author":"Jackson","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"50","key":"10.1016\/j.vaccine.2019.04.088_b0095","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1016\/j.vaccine.2010.09.034","article-title":"The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of health care personnel during a respiratory illness outbreak","volume":"28","author":"Talbot","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.088_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"15","key":"10.1016\/j.vaccine.2019.04.088_b0105","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2015.12790","article-title":"Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations","volume":"314","author":"Sukumaran","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.088_b0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm6703a6","article-title":"Notes from the Field: Errors in Administration of an Excess Dosage of Yellow Fever Vaccine \u2013 United States, 2017","volume":"67","author":"McNeil","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.088_b0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0037-86822002000200008","article-title":"Low frequency of side effects following an incidental 25 times concentrated dose of yellow fever vaccine","volume":"35","author":"Rabello","year":"2002","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.088_b0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/S0037-86822002000500022","article-title":"Overdose of yellow fever vaccine: a preventable error?","volume":"35","author":"Nishioka","year":"2002","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.088_b0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0037-86822011000200025","article-title":"Overdose of yellow fever vaccine in the Southern region of Brazil","volume":"44","author":"Carneiro","year":"2011","journal-title":"Rev Soc Bras Med Trop"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T17:37:24Z","timestamp":1565113044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19305766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":25,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X19305766"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007\u20132017","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}